Soleno Therapeutics Inc Forecast, price target & analysts
Soleno Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Soleno Therapeutics Inc Classifications & Recommendation:
Soleno Therapeutics Inc Price Target
| Target Price | $122.40 |
| Price | $49.42 |
| Potential |
147.67%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Soleno Therapeutics Inc 2026 .
The average Soleno Therapeutics Inc target price is $122.40.
This is
147.67%
register free of charge
$152.25
208.07%
register free of charge
$107.06
116.63%
register free of charge
|
|
| A rating was issued by 18 analysts: 17 Analysts recommend Soleno Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Soleno Therapeutics Inc stock has an average upside potential 2026 of
147.67%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 146.46 |
13 Analysts have issued a sales forecast Soleno Therapeutics Inc 2025 . The average Soleno Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
14 Soleno Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Soleno Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.38 | -0.76 |
| 85.59% | 82.65% | |
| P/E | negative | |
| EV/Sales | 15.06 |
14 Analysts have issued a Soleno Therapeutics Inc forecast for earnings per share. The average Soleno Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Soleno Therapeutics Inc...
Current Soleno Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 27 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 20 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Jul 11 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
